Ali D. Fawaz - May 16, 2022 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
General Counsel and Secretary
Signature
/s/ Ali D. Fawaz
Stock symbol
TYRA
Transactions as of
May 16, 2022
Transactions value $
$0
Form type
4
Date filed
5/16/2022, 08:38 PM
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TYRA Stock Option (Right to Buy) Award $0 +2.3K $0.00 2.3K May 16, 2022 Common Stock 2.3K $7.68 Direct F1, F2
transaction TYRA Stock Option (Right to Buy) Award $0 +3.75K $0.00 3.75K May 16, 2022 Common Stock 3.75K $7.68 Direct F1
transaction TYRA Stock Option (Right to Buy) Award $0 +362K $0.00 362K May 16, 2022 Common Stock 362K $7.68 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests based on achievement of a performance objective.
F2 25% of the shares subject to the option shall vest on May 16, 2023, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.